CAS No. |
1616632-77-9 |
中文名称 |
7-苄基-4-(2-甲基苄基)-1,2,6,7,8,9-六氢咪唑并[1,2-a]吡啶并[3,4-e]嘧啶-5(4H)-酮 |
英文名称 |
7-Benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(4H)-one |
别名 |
1616632-77-9 | ONC 201 | ONC-201 | ONC201 | Dordaviprone | 7-Benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5(4H)-one | TIC10 compound | NSC-350625 | 9U35A31JAI | UNII-9U35A31JAI | MFCD28118993 | NSC 350625 | 11-benzyl-7-[(2-methylphenyl)meth |
标准英文名 |
7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one |
MDL No. |
MFCD28118993 |
分子式 |
C24H26N4O |
分子量 |
386.50
|
精确分子量 |
386.21
|
SMILES |
CC1=CC=CC=C1CN1C(=O)C2=C(CCN(CC3=CC=CC=C3)C2)N2CCN=C12 |
标准SMILES |
CC1=CC=CC=C1CN1C(=O)C2CN(CC3C=CC=CC=3)CCC=2N2CCN=C21 |
用途 |
ONC201 (TIC10) is a potent anticancer agent that inhibits Akt and ERK signaling, leading to FoxO3a-dependent upregulation of TNF-related apoptosis-inducing ligand (TRAIL) and its death receptor DR5, thereby inducing p53-independent, Bax-dependent apoptosis in a broad spectrum of cancer cell lines; it exhibits superior stability, favorable pharmacokinetics, blood-brain barrier penetrability, and selective toxicity toward tumor cells while sparing normal fibroblasts; it is currently in Phase 1/2 clinical trials for the treatment of various malignancies. |
InChIKey |
VLULRUCCHYVXOH-UHFFFAOYSA-N |